Open AccessEGFR and HER2 expression in advanced biliary tract cancer
Author(s) -
Jan Harder,
Oliver Waiz,
Florian Otto,
Michael Geißler,
Manfred Olschewski,
Brigitte Weinhold,
Hubert E. Blum,
Annette Schmitt-Gräeff,
Oliver G. Opitz
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.4511
Subject(s) - medicine , epidermal growth factor receptor , immunohistochemistry , gallbladder cancer , cancer , gallbladder , biliary tract cancer , pathology , biopsy , concordance , oncology , gastroenterology , gemcitabine
To analyze the pathogenetic role and potential clinical usefulness of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2) in patients with advanced biliary tract cancer (BTC).